New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
Prince Reports 27.43 Metres Grading 93.7 g/t Silver, 12.0% Mn, 2.29% Pb and 2.48% Zn at Its Prince Silver Project in Nevada;
Market One: Standard Uranium Ltd. Prepares to Drill Its Flagship Davidson River Uranium Project in Saskatchewan's Athabasca Basin
West High Yield Resources Receives Draft Environmental Management Act Permit for Record Ridge Project
